News & Updates

Show Multimedia Only

Low-dose isotretinoin plus supramolecular salicylic acid safe, effective in acne treatment

08 Jun 2022

In the treatment of patients with acne vulgaris, chemical peeling with supramolecular salicylic acid in combination with low-dose isotretinoin is safe and produces rapid improvement in lesion clearance, as shown in a study.

08 Jun 2022

Zinc supplementation confers no benefit in prediabetes

08 Jun 2022

Supplementation with zinc does not help with glucose control in individuals with prediabetes, according to data from the Zinc in Preventing the Progression of pre-Diabetes (ZIPPeD) study.

08 Jun 2022

Long-term steroid OK for RA but challenges guidelines

08 Jun 2022 by

Contrary to what current guidelines advocate, long-term use of corticosteroid works fine in older patients with rheumatoid arthritis (RA), suggests the much-anticipated GLORIA* trial presented at EULAR 2022.

08 Jun 2022

Microbiome-based therapy for recurrent CDI hits mark in patients with comorbidities

07 Jun 2022 by

The investigational microbiota-based live biotherapeutic RBX2660 is safe and averts repeat episodes of Clostridioides difficile infection (CDI) across patient populations with comorbid conditions, as shown in a study presented at Digestive Disease Week (DDW) 2022.

07 Jun 2022

High-dose iberdomide shows promise in phase II SLE trial

07 Jun 2022 by

In a phase II trial evaluating three doses of the high-affinity cereblon modulator iberdomide, the 0.45-mg dose demonstrated superiority over placebo for individuals with active, moderate-to-severe systemic lupus erythematosus (SLE).

07 Jun 2022

Erlotinib lowers polyp burden in familial adenomatous polyposis

07 Jun 2022

Treatment with erlotinib is well tolerated and leads to a reduction in duodenal and lower gastrointestinal polyp burden in patients with familial adenomatous polyposis, according to data from a phase II trial.

07 Jun 2022

Tenapanor improves symptoms in patients with IBS-C

07 Jun 2022 by

Treatment with tenapanor improves symptoms in patients with irritable bowel syndrome with constipation (IBS-C) as early as week 1 of treatment, according to two phase III studies presented at DDW 2022.

07 Jun 2022

Imatinib may reduce mortality in hospitalized COVID-19 patients

06 Jun 2022 by

The tyrosine kinase inhibitor imatinib may reduce mortality in patients hospitalized with severe COVID-19, according to follow-up results of the CounterCOVID study presented at ATS 2022.

06 Jun 2022

Antibiotics identified as culprit for older-onset IBD

06 Jun 2022 by

Antibiotic use appears to be harmful for older adults, with a recent study showing that regardless of class, the drugs raise the risk of developing inflammatory bowel disease (IBD).

06 Jun 2022

School-based HPV vax scheme a success in Singapore

06 Jun 2022 by

An immunization program implemented in Singapore schools has achieved high coverage in vaccinating students against the human papillomavirus (HPV), reports a study.

06 Jun 2022

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Low-dose isotretinoin plus supramolecular salicylic acid safe, effective in acne treatment

Zinc supplementation confers no benefit in prediabetes

Long-term steroid OK for RA but challenges guidelines

Microbiome-based therapy for recurrent CDI hits mark in patients with comorbidities

High-dose iberdomide shows promise in phase II SLE trial

Erlotinib lowers polyp burden in familial adenomatous polyposis

Tenapanor improves symptoms in patients with IBS-C

Imatinib may reduce mortality in hospitalized COVID-19 patients

Antibiotics identified as culprit for older-onset IBD

School-based HPV vax scheme a success in Singapore